Coronary Artery Disease. For morbidity, duration as used in categories I21, I22, I24 and I25 refer to the interval elapsing between onset of the ischaemic episode and admission to care. For mortality, duration refers to the interval elapsing between onset and death.
Conditions
Interventions
Intervention group:.
Sponsors
Shiraz University of Medical Sciences
Eligibility
Sex/Gender
All
Age
18 Years to No maximum
Inclusion criteria
Inclusion criteria: Patients of age more than ??-year-old with minimum ?? % ejection fraction and triple vessel coronary artery disease referred for elective isolated coronary artery bypass grafting (CABG) surgery needing cardiopulmonary bypass will be included .
Exclusion criteria
Exclusion criteria: Patients with a history of previous cardiac surgery, chronic renal disease (had a previous medical diagnosis or serum creatinine greater than 1.5 mg/dL), perioperative pregnancy, an implanted pacemaker or intracardiac defibrillator, patient requiring preoperative mechanical support, severe psychiatric illness, and inability or unwillingness to give informed consent for participation will be excluded.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Ventricular fibrillation. Timepoint: After removing the aorta clamp. Method of measurement: Electrocardiogram.;Troponin and CK-MB Level. Timepoint: Immediately after the operation and 6 hours after the operation. Method of measurement: Lab Data. | — |
Secondary
| Measure | Time frame |
|---|---|
| ICU stay,. Timepoint: The days after the operation. Method of measurement: Number of days of hospitalization. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactDr. Mohammad Ghazi Noor
Shiraz University of Medical Sciences
Outcome results
None listed